Development of Potent, Selective cPLA2 Inhibitors for Targeting Neuroinflammation in Alzheimer’s Disease and Other Neurodegenerative Disorders

CTSA https://www.nature.com/articles/s44386-025-00035-0 2026-01-07T00:00:00Z npj Drug Discovery